ADVANCED TARGETING SYSTEMS for specific elimination of cell types

Slides:



Advertisements
Similar presentations
The human immune system
Advertisements

CENTER FOR BIOLOGICAL SEQUENCE ANALYSIS Department of Systems Biology Technical University of Denmark Immunological Bioinformatics Introduction to the.
Viruses, part 2.
Endocytosis & Exocytosis Pooja Patel Elizabeth Pemberton.
Cell Ultrastructure. Parts of a cell Standard grade level required only 3 parts of an animal cell. Now we have to learn around 15!
Cell Organelles Section 3.2, Part 2. Endoplasmic Reticulum (ER) An interconnected network of thin folded membranes (forms maze of enclosed spaces). –
Nanoparticle is a general term covering any structure built on a nanometer scale. In medical science, nanoparticles are structures on a nm scale,
Virus: A biological particle composed of nucleic acid and protein Intracellular Parasites: organism that must “live” inside a host What is a Virus?
Ch Immunity. Characteristics of Vertebrate immunity B& T lymphocytes distinguish “self” from “non- self” B& T lymphocytes distinguish “self”
The path of a protein. The cell’s main job is to create proteins.
 Virus: A biological particle composed of nucleic acid and protein  Intracellular Parasites: organism that must “live” inside a host.
Reproduce They have DNA or RNA They can adapt to surroundings The have organization They are not made of cells or organelles They cannot reproduce without.
Learning Target: Virus Anatomy and Physiology
Cell Organelles Section 3.2, Part 2.

Schema for a human microbiome study
Developing chemically modified, non-anticoagulant heparin derivatives as galectin-3-targeted novel anti-cancer/anti-metastasis drugs Professor Lu-Gang.
The History of a Lysosomal Enzyme
Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.
Week 18 – Lesson 1 From DNA to Protein Review
What is antibody screening While conventional cancer therapies (surgery, chemo therapy, and radiation therapy) have shown some success in the battle again.
A Closer Look at Cell Membranes
A Roadmap to Safe, Efficient, and Stable Lentivirus-Mediated Gene Therapy with Hematopoietic Cell Transplantation  Anton Neschadim, MSc, J. Andrea McCart,
Sachs Annual Biotech in Europe Forum
The PI3K/Akt signalling and its activation in cancer
The hallmarks of adenovirus infection
The cellular immune response to cancer is complex and involves a diverse repertoire of immunoregulatory interactions principally involving antigen presenting.
Schematic diagram of antibody drug conjugate
How Medicines Work: Stimulation and Inhibition
Vocabulary Review Chapter 3 - Cells.
The core pillars and thematic hallmarks of anti-tumour immunity governing response to immune checkpoint blockade Figure 2 from Cogdill et al. British.
(A) An overview of the JAK/STAT signalling pathway.
Molecular approaches to HER2 targeted therapy
NAME: PERIOD: Form a.
small structures on surface Form A 2.
An overview of oncogenic KRAS-driven RAF/MEK/ERK and PI3K/PDK1/AKT signalling networks in pancreatic cancer Figure 1 from Eser et al. British Journal.
Model of the function of TBX2 in RMS.
Figure 2 from Sancho et al.
The cancer stem cell concept in cancer progression and metastasis
Viruses Viruses – are segments of nucleic acids
The putative genomic evolution of prostate cancer from normal epithelium to castrate-resistant, metastatic cancer Figure 2 from Mitchell and Neal British.
Figure 1 from B Zhu British Journal of Cancer (2015) 112, ; doi: /bjc
Sequencing of targeted therapies in HER2-positive metastatic breast cancer Figure 2 from Singh et al. British Journal of Cancer (2014) 111,
small structures on surface Form B 7.
A hypothetical scheme targeting autophagy for glioblastoma sensitisation during radio-chemotherapy with TMZ Figure 1 from Michael I Achilleas G and.
Figure 1 from M Holderfield
Molecular features of the colon during homeostasis and carcinogenesis
Figure 1 from T Schenk et al.
Parts of a Cell Seen with an Electron Microscope
small structures on surface Form B 7.
small structures on surface Form A 2.
Fbxw7 ablation in LICs for CML sensitises the cells to imatinib by preventing quiescence. Figure 2 from S Takeishi British Journal of Cancer (2014) 111,
HDACs class I, II, IV mutations in human cancer
NAME: PERIOD: Form b.
NAME: PERIOD: Form a.
US Army Medical Research and Materiel Command
In melanoma tumours expressing the BRAFV600E oncogene RAF inhibitor treatment decreases ERK activation resulting in tumour regression and increased survival.
Mitochondrial priming model
Viruses & other Pathogens
Spectrum of cellular processes regulated by AXL activity
Viruses Doesn’t belong to any kingdom -It’s not a plant or an animal.
Figure 1 from D’Incalci et al.
Involvement of actin cytoskeletal reorganisation in EMT
The F-box protein Fbxw7 is required for maintenance of normal stem cells. Figure 1 from S Takeishi British Journal of Cancer (2014) 111, ; doi: /bjc
Target antigens for ADCs in solid tumours
Macrophage differentiation and their role in tumourigenesis
Model of EphA/ephrin-A expression in GBM.
The Cell in its Environment
Viruses Viruses – are segments of nucleic acids
Parts of a Cell Seen with an Electron Microscope
Presentation transcript:

ADVANCED TARGETING SYSTEMS for specific elimination of cell types 7

1. Get an antibody specific to your cell type Or, you can use a growth factor, peptide, or cytokine ANTIBODY 7

2. Use a potent toxin that is safe in the lab, but lethal inside a cell. SAPORIN 7

3. ATS puts them together to make a powerful targeting agent 7

Targeted Toxins can be used in vitro or in vivo 7

Targeted Toxins can be used in vitro or in vivo 7

The antibody seeks out its target receptor on the cell’s surface. 7

The antibody seeks out its target receptor on the cell’s surface. 7

Without its escort, SAPORIN cannot get inside a cell. 7

Without its escort, SAPORIN cannot get inside a cell. 7

Once attached to its target receptor, the conjugate is internalized. 7

Once attached to its target receptor, the conjugate is internalized. 7

Once attached to its target receptor, the conjugate is internalized. 7

Once attached to its target receptor, the conjugate is internalized. 7

have the target receptor will not be affected. Cells which do not have the target receptor will not be affected. 7

have the target receptor will not be affected. Cells which do not have the target receptor will not be affected. 7

have the target receptor will not be affected. Cells which do not have the target receptor will not be affected. 7

have the target receptor will not be affected. Cells which do not have the target receptor will not be affected. 7

have the target receptor will not be affected. Cells which do not have the target receptor will not be affected. 7

The SAPORIN conjugate enters the cell. 7

The SAPORIN conjugate enters the cell. 7

The SAPORIN conjugate enters the cell. 7

The SAPORIN conjugate enters the cell. 7

Once inside, SAPORIN will inactivate the ribosome. 7

Once inside, SAPORIN will inactivate the ribosome. 7

Once inside, SAPORIN will inactivate the ribosome. 7

The result is cell death. 7

The result is cell death. 7

The result is cell death. 7

The conjugate is carried inside the cell. coated vesicle 7

coated vesicle 7

coated vesicle 7

coated vesicle 7

coated vesicle 7

7

7

Saporin escapes Ribosomes Golgi 7

Ribosomes Golgi 7

Ribosomes Golgi 7

SAPORIN inactivates the ribosome Ribosomes SAPORIN inactivates the ribosome Golgi 7

RIP Ribosomes SAPORIN inactivates the ribosome R I P Golgi 7

SAPORIN inactivates the ribosome R I P 7

SAPORIN inactivates the ribosome R I P R I P 7

R I P R I P 7

R I P R I P R I P 7

The result is Cell Death R I P R I P R I P 7

R I P R I P R I P R I P 7

R I P R I P R I P R I P 7

R I P R I P R I P R I P R I P 7

R I P R I P R I P R I P R I P 7

R I P R I P R I P R I P R I P R I P 7

R I P R I P R I P R I P R I P R I P 7

R I P R I P R I P R I P R I P R I P R I P 7

R I P R I P R I P R I P R I P R I P R I P 7

ADVANCED TARGETING SYSTEMS for specific elimination of cell types 7

Saporin Saporin (pronounced sap – r – n) e e ⏝ Saporin (pronounced sap – r – n) e e Saporin is a ribosome-inactivating protein. Molecular weight – 30 kDa From the seeds of the plant, Saponaria officinalis Saporin is safe for laboratory use under normal safety conditions LD50 in mice – 4 mg/kg Saporin does not have a method of cell entry on its own, except through bulk-phase endocytosis

Advanced Targeting Systems also provides Custom Conjugations to use your Targeting Agent to deliver any Payload. Targeting Agent * Antibody Peptide Ligand Aptamer Growth Factor Cytokine Payload Toxin Drug Killing Agent Activating Agent Reversible Agent * Anything that is recognized on the cell surface and internalizes www.ATSbio.com